Revodil 6.25 mg (Tablet)
Unit Price: ৳ 3.00 (4 x 10: ৳ 120.00)
Strip Price: ৳ 30.00
Medicine Details
Category | Details |
---|---|
Generic | Carvedilol |
Company | Ibn sina pharmaceuticals ltd |
Indications
- Treatment of mild, moderate or severe heart failure
- Reduction of disease progression
- Use in patients unable to tolerate ACE inhibitor
- Use in patients not receiving specific therapies
Pharmacology
- Non-selective antagonism of β-adrenergic receptors
- α-adrenergic antagonistic activity
- Antiproliferative properties
- Scavenger of reactive free oxidant radicals
Dosage & Administration
- Initial dose for hypertension: 12.5 mg once daily
- Recommended dose for angina pectoris: 12.5 mg twice daily
- Initial dose for heart failure: 3.125 mg twice daily
- Maximum daily doses for different conditions
Interaction
- Effect on digoxin levels
- Effect on rifampin
- In vitro plasma protein binding of warfarin
- Potentiation of clonidine withdrawal reaction
Contraindications
- Decompensated heart failure with intravenous inotropic therapy
- Bronchial asthma or related bronchospastic conditions
- Second or third-degree AV block
- Cardiogenic shock or severe bradycardia
Side Effects
- Postural hypotension
- Dizziness
- Gastro-intestinal disturbances
- Peripheral oedema
- Dry mouth and eyes
- Impotence
- Exacerbation of psoriasis
- Changes in liver enzymes
- Thrombocytopenia
- Leukopenia
Pregnancy & Lactation
- Avoid use during breast-feeding and pregnancy
- Potential excretion in breast milk
- Crossing the placental barrier
- Safety and efficacy in children and neonates not established
Precautions & Warnings
- Caution in hepatic impairment
- Monitor clinical status after initiation and increasing doses
- Ensure renal function and heart failure are not deteriorating before increasing dose
Therapeutic Class
- Alpha adrenoceptor blocking drugs
- Beta-adrenoceptor blocking drugs
- Beta-blockers
Storage Conditions
- Keep below 30°C temperature
- Away from light and moisture
- Keep out of the reach of children